Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)

V. Moreno, M. Gil-Martin, M. Johnson, R. Aljumaily, P. Lopez Criado, D. W. Northfelt, M. Crittenden, S. Jabbour, L. Rosen, P. Garrido Lopez, A. Hervás Morón, P. Rietschel, K. K. Mohan, J. Li, E. Stankevich, T. Rowlands, M. Feng, I. Lowy, M. G. Fury

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)viii414
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this